跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Risk stratification in patients with hypertrophic cardiomyopathy: Looking beyond the left side myocardial function
Hao Chih Chang
,
Hao Min Cheng
, Ling Kuo
, Dan Ying Lee
,
Shih Hsien Sung
,
Chen Huan Chen
, Wen Chung Yu
*
*
此作品的通信作者
醫學系內科學科
研究成果
:
Article
›
同行評審
3
引文 斯高帕斯（Scopus）
總覽
指紋
指紋
深入研究「Risk stratification in patients with hypertrophic cardiomyopathy: Looking beyond the left side myocardial function」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Risk Stratification
100%
Left-handed
100%
Hypertrophic Cardiomyopathy
100%
Myocardial Function
100%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
83%
Right Ventricular Free Wall Strain
66%
Right Ventricular Function
50%
Left Ventricular Ejection Fraction
33%
Confidence Interval
33%
Hazard Ratio
33%
Cardiovascular Events
16%
Comprehensive Evaluation
16%
All-cause Mortality
16%
Heart Failure Hospitalization
16%
Retrospective Cohort Study
16%
Functional Parameters
16%
Tracking Method
16%
Prognostic Factors
16%
Prognostic Value
16%
Sustained Ventricular Tachycardia
16%
Follow-up Interval
16%
Speckle Tracking
16%
Cardiac Events
16%
Longitudinal Strain
16%
Net Reclassification Improvement
16%
Fractional Area Change
16%
Incremental Prognostic Value
16%
LV Strain
16%
Segmental Strain
16%
Excursion Area
16%
Medicine and Dentistry
Risk Stratification
100%
Heart Function
100%
Hypertrophic Cardiomyopathy
100%
Right Ventricular Function
50%
Hazard Ratio
33%
Heart Left Ventricle Ejection Fraction
33%
Cardiovascular System
16%
Retrospective Cohort Study
16%
Cause of Death
16%
Congestive Heart Failure
16%
Sustained Ventricular Tachycardia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertrophic Cardiomyopathy
100%
Heart Ventricle Tachycardia
16%
Congestive Heart Failure
16%
Cohort Study
16%
Cause of Death
16%
Immunology and Microbiology
Heart Function
100%
Heart Left Ventricle Ejection Fraction
66%